Last updated on February 2018

Efficacy of Ferric Carboxymaltose (Ferinject ) in Anemic Patients Anticipating Pancreatoduodenectomy

Brief description of study

This phase II study is to evaluate the safety and efficacy of Ferinject in reducing perioperative transfusion in iron deficiency anemia patients anticipating pancreatoduodenectomy.

Detailed Study Description

Primary objectives : Perioperative transfusion rate (including preop, intraop, postop7 days).

Secondary objectives : Postoperative complication, hospital stay, change of hematological parameters (Hb, ferritin, transferrin saturation (TSAT) change after Ferinject injection), adverse effect with Ferinject injection.

Clinical Study Identifier: NCT02628860

Contact Investigators or Research Sites near you

Start Over

Sang Jae Park, MD

National Cancer Center
Goyang, Korea, Republic of
  Connect »